Vaxess Technologies
Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics. For vaccines, the controlled release simulates the pace of a natural infection, helping the body produce a slow, strong, and enduring ramp-up of immune response, ultimately boosting a vaccine’s effectiveness. Engineered for stability, Vaxess’s patch does not require refrigeration and can be shipped to and applied in low resource settings.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Vaxess Technologies use?+
Vaxess Technologies uses 11 technologies including Adobe Fonts, reCAPTCHA, core-js.
What industry is Vaxess Technologies in?+
Vaxess Technologies operates in the Biotechnology industry.
Where is Vaxess Technologies based?+
Vaxess Technologies is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026